Literature DB >> 31142677

Accurate needle-free assessment of myocardial oxygenation for ischemic heart disease in canines using magnetic resonance imaging.

Hsin-Jung Yang1,2, Ilkay Oksuz3, Damini Dey1,2, Jane Sykes4, Michael Klein5, John Butler4, Michael S Kovacs4, Olivia Sobczyk5, Ivan Cokic1, Piotr J Slomka1,2, Xiaoming Bi6, Debiao Li1,2, Mourad Tighiouart1, Sotirios A Tsaftaris7, Frank S Prato4, Joseph A Fisher5, Rohan Dharmakumar8,2.   

Abstract

Myocardial oxygenation-the ability of blood vessels to supply the heart muscle (myocardium) with oxygen-is a critical determinant of cardiac function. Impairment of myocardial oxygenation is a defining feature of ischemic heart disease (IHD), which is caused by pathological conditions that affect the blood vessels supplying oxygen to the heart muscle. Detecting altered myocardial oxygenation can help guide interventions and prevent acute life-threatening events such as heart attacks (myocardial infarction); however, current diagnosis of IHD relies on surrogate metrics and exogenous contrast agents for which many patients are contraindicated. An oxygenation-sensitive cardiac magnetic resonance imaging (CMR) approach used previously to demonstrate that CMR signals can be sensitized to changes in myocardial oxygenation showed limited ability to detect small changes in signals in the heart because of physiologic and imaging noise during data acquisition. Here, we demonstrate a CMR-based approach termed cfMRI [cardiac functional magnetic resonance imaging (MRI)] that detects myocardial oxygenation. cfMRI uses carbon dioxide for repeat interrogation of the functional capacity of the heart's blood vessels via a fast MRI approach suitable for clinical adoption without limitations of key confounders (cardiac/respiratory motion and heart rate changes). This method integrates multiple whole-heart images within a computational framework to reduce noise, producing confidence maps of alterations in myocardial oxygenation. cfMRI permits noninvasive monitoring of myocardial oxygenation without requiring ionizing radiation, contrast agents, or needles. This has the potential to broaden our ability to noninvasively identify IHD and a diverse spectrum of heart diseases related to myocardial ischemia.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31142677     DOI: 10.1126/scitranslmed.aat4407

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  5 in total

Review 1.  Biomedical Imaging in Experimental Models of Cardiovascular Disease.

Authors:  David E Sosnovik; Marielle Scherrer-Crosbie
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 2.  Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.

Authors:  B Wilk; G Wisenberg; R Dharmakumar; J D Thiessen; D E Goldhawk; F S Prato
Journal:  J Nucl Cardiol       Date:  2019-12-03       Impact factor: 5.952

3.  Blood Oxygen Level-Dependent MRI of the Myocardium with Multiecho Gradient-Echo Spin-Echo Imaging.

Authors:  Maaike van den Boomen; Mary Kate Manhard; Gert Jan H Snel; SoHyun Han; Kyrre E Emblem; Riemer H J A Slart; David E Sosnovik; Ciprian Catana; Bruce R Rosen; Niek H J Prakken; Christopher T Nguyen; Ronald J H Borra; Kawin Setsompop
Journal:  Radiology       Date:  2020-01-21       Impact factor: 29.146

4.  Feasibility of MRI based oxygenation imaging for the assessment of acute limb ischemia.

Authors:  Bihui Zhang; Chengyan Wang; Haochen Wang; Hanjing Kong; Fei Gao; Min Yang; Jue Zhang
Journal:  Ann Transl Med       Date:  2020-03

5.  Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2.

Authors:  Fei Fu; Qiong Lai; Jingui Hu; Lu Zhang; Xiaozhou Zhu; Junping Kou; Boyang Yu; Fang Li
Journal:  Antioxidants (Basel)       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.